Table 5 Comparison of tumor size between sessile serrated adenomas/polyps without and with dysplasia or adenocarcinoma groups according to removal method and age groups.

From: Clinical and endoscopic characteristics of sessile serrated adenomas/polyps with dysplasia/adenocarcinoma in a Korean population: A Korean Association for the Study of Intestinal Diseases (KASID) multicenter study

Removal methods

Tumor size of SSA/Ps (mm) [mean ± SD] (range)

Total (n = 532)

    Polypectomy (n = 95)

6.2 ± 5.9 (2.0–30.0)

    EMR (n = 412)

10.8 ± 6.0 (2.0–40.0)

    EPMR (n = 5)

27.0 ± 8.3 (15.0–35.0)

    ESD (n = 20)

27.5 ± 12.6 (6.0–50.0)

Variables

SSA/POs (n = 370)

SSA/PDAs (n = 162)

p-value

Tumor size (n) (%)

    <10 mm (n = 271)

194 (52.4)

77 (47.5)

0.268

    10–20 mm (n = 190)

124 (33.5)

66 (40.7)

0.271

    ≥20 mm (n = 71)

52 (14.1)

19 (11.7)

0.700

Age [mean ± SD] (n)

   Age <58 (n = 263)

    Polypectomy (n = 46)

4.5 ± 2.7 (39)

7.0 ± 4.5 (7)

0.210

    EMR (n = 209)

10.9 ± 5.8 (142)

10.1 ± 5.5 (67)

0.337

    EPMR (n = 2)

27.0 ± 7.0 (2)

0(0)

NA

    ESD (n = 6)

32.5 ± 8.6 (4)

46.0 ± 5.6 (2)

0.100

   Age ≥58 (n = 269)

    Polypectomy (n = 49)

6.8 ± 6.6 (43)

11.6 ± 8.1 (6)

0.213

    EMR (n = 203)

11.2 ± 6.4 (129)

10.2 ± 5.7 (74)

0.257

    EPMR (n = 3)

33.0 ± 2.8 (2)

15.0 (1)

0.121

    ESD (n = 14)

23.5 ± 9.1 (9)

23.2 ± 16.5 (5)

0.966

  1. SD, standard deviation; SSA/Ps, sessile serrated adenoma/polyps; EMR, endoscopic mucosal resection; EPMR, endoscopic piecemeal mucosal resection; ESD, endoscopic submucosal dissection; SSA/POs, SSA/Ps without dysplasia; SSA/PDAs, SSA/Ps with dysplasia or adenocarcinoma; NA, not available.